Avanos Medical (AVNS) EPS (Weighted Average and Diluted) (2016 - 2025)
Avanos Medical (AVNS) has disclosed EPS (Weighted Average and Diluted) for 12 consecutive years, with -$0.02 as the latest value for Q4 2025.
- Quarterly EPS (Weighted Average and Diluted) rose 99.77% to -$0.02 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.57 through Dec 2025, up 81.42% year-over-year, with the annual reading at -$1.57 for FY2025, 81.59% up from the prior year.
- EPS (Weighted Average and Diluted) hit -$0.02 in Q4 2025 for Avanos Medical, up from -$0.03 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.82 in Q4 2022 to a low of -$8.64 in Q4 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.57 across 5 years, with a median of -$0.01 in 2024.
- Biggest five-year swings in EPS (Weighted Average and Diluted): soared 1416.67% in 2021 and later crashed 1944.44% in 2025.
- Year by year, EPS (Weighted Average and Diluted) stood at $0.24 in 2021, then surged by 241.67% to $0.82 in 2022, then crashed by 206.1% to -$0.87 in 2023, then plummeted by 893.1% to -$8.64 in 2024, then surged by 99.77% to -$0.02 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for AVNS at -$0.02 in Q4 2025, -$0.03 in Q3 2025, and -$1.66 in Q2 2025.